credit rating

credit risk

Pharma

Want to bet on Big Pharma? M&A hunger increases risk: S&P

Thanks to M&A and drug pricing pressure, S&P believes it will hand out more company downgrades than upgrades in 2021 among large pharmas.

Angus Liu Feb 24, 2021 1:03pm

Teva

Teva's debt-easing options narrow as Fitch cuts rating to junk

Nov 7, 2017 12:20pm

Valeant pitches creditors on higher interest rate, fees

Mar 31, 2016 10:04am